Medicofarma Biotech Spolka Akcyjna
MDB | WAR
Overview
Corporate Details
- ISIN(s):
- PLINBOK00010
- LEI:
- 259400W39H7UHW9EJP66
- Country:
- Poland
- Address:
- Warszawa Sokołowska 9/U19, 01-142 Warszawa
- Website:
- http://medicofarmabiotech.pl
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Medicofarma Biotech Spolka Akcyjna is a publicly-traded company dedicated to the development of innovative pharmaceuticals, medical products, and biotechnological solutions. Our mission is to create groundbreaking medications that enhance the prevention and treatment of modern diseases. We leverage cutting-edge technology and the expertise of seasoned specialists to drive our research initiatives. Our R&D center collaborates with pharmaceutical and cosmetic companies, as well as academic institutions, to provide comprehensive support in developing generics and cosmetics. We are actively seeking new scientific, clinical, and business partnerships to further our innovative projects, including cancer therapies and adaptogenic products. As we expand, we invite potential investors to join us on this transformative journey in healthcare.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-04-18 18:43 |
Share Issue/Capital Change
Wprowadzenie do ASO na rynku NewConnect akcji serii G i H oraz złożenie wniosku…
|
Polish | 1.3 KB | |
| 2024-03-06 19:35 |
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
|
Polish | 3.3 KB | |
| 2024-01-03 22:51 |
Share Issue/Capital Change
Złożenie wniosku o wprowadzenie akcji serii G i H do obrotu w ASO na rynku NewC…
|
Polish | 1.7 KB | |
| 2024-01-02 17:16 |
Share Issue/Capital Change
Korekta raportu bieżącego ESPI nr 11/2023 - Content (PL)
|
Polish | 4.5 KB | |
| 2023-12-31 19:41 |
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
|
Polish | 2.1 KB | |
| 2023-12-31 19:33 |
Legal Proceedings Report
Zawarcie umów ograniczających rozporządzanie akcjami Spółki - Content (PL)
|
Polish | 2.9 KB | |
| 2023-12-31 19:24 |
Investor Presentation
Strategia na lata 2024-2026
|
Polish | 2.6 MB | |
| 2023-12-31 19:24 |
Business and Financial Review
Przyjęcie strategii Spółki na lata 2024 - 2026 - Content (PL)
|
Polish | 1.8 KB | |
| 2023-10-26 22:42 |
Capital/Financing Update
Zawarcie aneksu do umowy pożyczki z podmiotami powiązanymi - Content (PL)
|
Polish | 2.5 KB | |
| 2023-10-23 20:42 |
Regulatory News Service
Zawarcie umowy o dofinansowanie projektu wybranego w ramach konkursu NUTRITECH …
|
Polish | 6.3 KB | |
| 2023-10-11 21:07 |
Legal Proceedings Report
Otrzymanie wyników wstępnego międzynarodowego poszukiwania dot. stanu techniki …
|
Polish | 1.9 KB | |
| 2023-07-20 19:38 |
Report Publication Announcement
Najwyższa ocena merytoryczna wniosku dotacyjnego NUTRITECH - Content (PL)
|
Polish | 1.2 KB | |
| 2023-07-19 18:01 |
Regulatory News Service
Informacja o uzyskaniu certyfikatu GMP - Content (PL)
|
Polish | 716 bytes | |
| 2023-06-30 22:59 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Walnym Zgroma…
|
Polish | 766 bytes | |
| 2023-06-02 15:22 |
Management Discussion and Analysis
Medicofarma_Biotech_SA_Sprawozdanie_Rady_Nadzorczej_2022_20230602_sent.pdf
|
Polish | 345.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |